This is a significant step forward in Clinovo’s growth. Matt’s experience leading CRO sales organizations is a natural complement to our management team’s key leadership, explains Ale Gicqueau, President & CEO at Clinovo.
San Diego, CA (PRWEB) April 20, 2011
Matt Smith, former CEO at Clinimetrics, joins Clinovo as VP of Business Operations, bringing with him over 20 years experience in executive leadership, clinical trial management, and business development within the contract research industry.
In this new position, Matt will expand Clinovo’s presence to the « Biotech Beach » in Southern California. « This is an exciting opportunity », says Matt. « I look forward to working with Clinovo’s team of experts. My aim is to continue grow Clinovo’s business through the new presence in San Diego, as well as through solid working relationships with all our valued customers. »
Prior to Clinovo, Matt was CEO and Chief Business Officer of Clinimetrics, a full-service contract research organization (CRO). Previously, he held roles of increasing responsibility at Quintiles in the area of Phase I-IV clinical trial operations, project management, and business development.
Matt brings to Clinovo a passion for developing high quality partnerships through strong client communication, as well as solid business management skills. His combined management and industry experience acquired in various leading CRO companies will help further expand Clinovo’s fast growing business and achieve greater geographic reach.
« This is a significant step forward in Clinovo’s growth», explains Ale Gicqueau, President & CEO at Clinovo. " Matt’s experience leading CRO sales organizations is a natural complement to our management team’s key leadership in Clinical Data Management, Biometrics, EDC and Clinical Solutions. This is also the first Clinovo office outside the San Francisco Bay Area.»
In addition to leading business operations at Clinovo, Matt is also acting as the managing director of Clinovo’s new San Diego office. As a successful biopharmaceutical cluster with one of the largest concentration of biotechnology companies worlwide, San Diego is a strategic location for Clinovo to increase its market share and start expanding its market outside the Bay Area.